This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
News: Publications

EAS Newsletter June 16, 2020

Wednesday 17 June 2020   (0 Comments)
Share |

EAS Publication

Featured Commentary: Familial hypercholesterolaemia - an urgent public health priority

Two global reports provide consistent data showing that heterozygous familial hypercholesterolaemia (FH) is common in the general population, and even more so among individuals with atherosclerotic cardiovascular disease. Mapping the global prevalence of FH is critical for informing public health policy to identify and treat FH early.

To the commentary FH - an urgent health priority >>

EAS supports FH Europe campaign

"When your heart says so... JustGo!"

All over Europe, the Covid pandemic has affected patients with cardiovascular disease and lipid disorders. Following guidance to “Stay at home”, and concerned about contracting the coronavirus disease, patients have interrupted their treatment regimens and those with symptoms  have waited too long to contact their doctor, and stayed away from hospital. When they eventually seek treatment, many have developed complications that have a negative effect on their recovery. Although most countries are now opening up, the fear continues and patients still prefer to stay home.

The European Atherosclerosis Society supports the “When Your Heart Says So... Just Go” campaign – we want everyone to know how important it is to seek help quickly at the first sign of heart problems, despite the current pandemic. #JustGo

Prof Lale Tokgozoglu, President of the European Atherosclerosis Society

The Global Heart Hub, together with FH Europe, have joined forces to lead a ‘patient-to-patient’ #JustGo Campaign. The campaign affirms medical advice to always act quickly when it comes to symptoms of a heart attack.

To the FH Europe campaign "When your heart say so... JustGo" >>

Good Clinical Trials Collaborative Global Survey - Clinical Trials and COVID-19

The Good Clinical Trials Collaborative invites you to take part in a global survey to understand the impact of COVID-19 on running clinical trials.

Your feedback will contribute to the development of new guidelines that support a more efficient regulatory environment for clinical trials, allowing researchers to efficiently conduct the trials that are needed to improve patient care.

The survey will be open for 6 weeks, closing at 5pm (BST) on Monday 20 July 2020.

To GCTC survey >>

New National Societies joining EAS!

EAS has close links with National Atherosclerosis Societies. Our collaborations with them include co-organising joint sessions at national society Congresses.

For Societies that affiliate to EAS, we offer to their members free access to Atherosclerosis Journal, access to selected content on EAS Academy, eligibility to apply for Advanced Courses, and newsletter updates.

We welcome our most recent National Society Members: Portuguese Atherosclerosis Society & Baltic Atherosclerosis Society.

To National Society list >>

Nominations to the Executive Committee

Thank you to everyone who has nominated, or been nominated, to the vacant positions in the EAS Executive Committee. Your support, to build a committed and representative leadership team - to develop and implement activities that fulfil our Society’s mission, is much appreciated.

Nominations for vacant EAS Executive Committee member and officer posts have been received and are under review by the Election Committee. 

To EAS Governance >>

Membership Software Powered by YourMembership  ::  Legal